Cargando…
Integrated analysis identifies microRNA‐188‐5p as a suppressor of AKT/mTOR pathway in renal cancer
Many current microRNA (miRNA) expression datasets for renal cell carcinoma (RCC) often show inconsistent analysis results, so a shift to comprehensive analysis of multiple datasets can effectively accelerate molecular screening for precision medicine and translational medicine research. MicroRNA (mi...
Autores principales: | Shen, Hui, Jin, Jing, Wang, Hang, Yu, Nanxi, Liu, Tingting, Sheng, Han, Wan, Zhijie, Feng, Chao, Huang, Yijuan, Gao, Fu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10394144/ https://www.ncbi.nlm.nih.gov/pubmed/37199297 http://dx.doi.org/10.1111/cas.15832 |
Ejemplares similares
-
MicroRNA-10a suppresses breast cancer progression via PI3K/Akt/mTOR pathway
por: Ke, Kongliang, et al.
Publicado: (2017) -
MicroRNA-99 Family Targets AKT/mTOR Signaling Pathway in Dermal Wound Healing
por: Jin, Yi, et al.
Publicado: (2013) -
MicroRNA‐188 regulates aging‐associated metabolic phenotype
por: Huang, Yan, et al.
Publicado: (2019) -
Escaping mTOR inhibition for cancer therapy: Tumor suppressor functions of mTOR
por: Villar, Victor H., et al.
Publicado: (2017) -
Antitumor activity of miR-188-3p in gastric cancer is achieved by targeting CBL expression and inactivating the AKT/mTOR signaling
por: Lin, Jian-Jiao, et al.
Publicado: (2023)